TerminatedNCT01809340

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

Medication studyAges 18–80Multiple countries

The study in practice

Understand this study

Listed age limits: 18 years to 80 years.

Listed locations: Duffel and 11 more locationsSee all locations and recruitment
Study phase: Phase 2

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateJune 2013

Recruitment status: Terminated
Enrollment listed in the registry: 29
Sponsor: Janssen Research & Development, LLC
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: France, Belgium, Netherlands, ...
Age range: From 18 Years to 80 Years
Official registry ID: NCT01809340
Official title: Show the full official title
An Exploratory, Blinded, Randomized, Placebo-controlled Study in Subjects With Depressive Disorder to Investigate the Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced (Partial) Symptoms Response

Terminated

Duffel, Belgium · Lede, Belgium · Leuven, Belgium

9 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Janssen Research & Development, LLC.

Does this study involve medication?

Yes. The study involves medication, including Minocycline, Placebo and ketamine.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as terminated.